<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-91089</identifier>
<setSpec>1138-3593</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Oral biphosponate related osteonecrosis of the jaw: a case report</dc:title>
<dc:description xml:lang="en">Bisphosphonates are widely used medicines in Primary Care, particularly in the treatment of postmenopausal osteoporosis. It is also used in oncological patients with bone metastasis, in multiple myeloma, Paget's disease and malignant hypercalcemia. Even though they are generally well tolerated drugs, they are not free of side effects, the worse of which is the osteonecrosis of the jaw (AU)</dc:description>
<dc:creator>Martínez Morentin, M</dc:creator>
<dc:creator>Echeveste Inzagaray, J. M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Los bifosfonatos son fármacos ampliamente empleados en atención primaria, principalmente en osteoporosis posmenopáusica, pero también en pacientes oncológicos con metástasis óseas, así como en el mieloma múltiple, enfermedad de Paget y en la hipercalcemia maligna. A pesar de ser fármacos generalmente bien tolerados, no están exentos de efectos adversos, siendo uno de los más temibles la osteonecrosis mandibular (AU)</dc:description>
<dc:source>SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.);37(8): 430-432, oct. 2011.</dc:source>
<dc:identifier>ibc-91089</dc:identifier>
<dc:title xml:lang="es">Osteonecrosis mandibular relacionada con la toma de bifosfonatos por vía oral: a propósito de un caso</dc:title>
<dc:subject>^d33384^s22073</dc:subject>
<dc:subject>^d24235^s22016</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d10200^s22012</dc:subject>
<dc:subject>^d24235^s22012</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d9555^s22032</dc:subject>
<dc:subject>^d10200^s22036</dc:subject>
<dc:subject>^d8506^s22009</dc:subject>
<dc:subject>^d4220^s22020</dc:subject>
<dc:subject>^d10200^s22016</dc:subject>
<dc:subject>^d24235^s29166</dc:subject>
<dc:subject>^d4220^s22073</dc:subject>
<dc:subject>^d1731^s22045</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:subject>^d1731^s22039</dc:subject>
<dc:subject>^d8506^s22053</dc:subject>
<dc:subject>^d8506^s29166</dc:subject>
<dc:type>article</dc:type>
<dc:date>201110</dc:date>
</metadata>
</record>
</ibecs-document>
